Fennec Pharmaceuticals Financial Overview
Fennec Pharmaceuticals's market cap is currently $265.37M. The company's EPS TTM is $-0.020320692; its P/E ratio is -32.23; Fennec Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
